• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国一家大型学术医疗中心的持续性肾脏替代治疗给药模式。

Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States.

作者信息

Venkataraman Ramesh, Kellum John A, Palevsky Paul

机构信息

Department of Critical Care Medicine, University of Pittsburgh School of Medicine and Veteran's Affairs Pittsburgh Healthcare System, Pittsburgh, PA 15261, USA.

出版信息

J Crit Care. 2002 Dec;17(4):246-50. doi: 10.1053/jcrc.2002.36757.

DOI:10.1053/jcrc.2002.36757
PMID:12501152
Abstract

PURPOSE

We sought to retrospectively review the dosing patterns of continuous renal replacement therapy (CRRT) in patients with acute renal failure (ARF) and determine their actual delivered dosage of CRRT.

MATERIALS AND METHODS

Computerized records of patients (n = 115) who received CRRT for ARF at a single, large, academic, tertiary care hospital from September 1, 1999 through August 31, 2000 were reviewed. The delivered dose of CRRT for each patient/day was calculated from the hourly effluent flow rate, the patient's weight, and the duration (in hours) of CRRT for that day. A mean effluent flow rate (in L/h) for each patient was then calculated.

RESULTS

The average number of hours/day on CRRT was 16.1 +/- 3.53 (mean +/- SD), with a mean flow rate (averaged over 24 h) of 1.36 +/- 0.31 L/h. The mean CRRT dose prescribed for these patients was 24.46 +/- 6.73 mL/Kg/h, but the mean dose delivered was only 16.55 +/- 5.41 mL/Kg/h (68% of the prescribed dose, P <.000001).

CONCLUSIONS

Many patients are prescribed low doses of CRRT. Furthermore, the dose delivered is considerably lower than that prescribed. Methods and procedures to extend CRRT system life may improve the dose delivery.

摘要

目的

我们试图回顾性分析急性肾衰竭(ARF)患者连续肾脏替代治疗(CRRT)的剂量模式,并确定其实际接受的CRRT剂量。

材料与方法

回顾了1999年9月1日至2000年8月31日在一家大型学术性三级医疗中心接受ARF的CRRT治疗的患者(n = 115)的计算机记录。根据每小时的流出液流速、患者体重以及当天CRRT的持续时间(小时)计算每位患者每天的CRRT剂量。然后计算每位患者的平均流出液流速(L/h)。

结果

CRRT每天的平均时长为16.1±3.53(均值±标准差),平均流速(24小时平均值)为1.36±0.31L/h。这些患者的CRRT处方平均剂量为24.46±6.73mL/kg/h,但实际平均剂量仅为16.55±5.41mL/kg/h(为处方剂量的68%,P<.000001)。

结论

许多患者接受的CRRT剂量较低。此外,实际给予的剂量远低于处方剂量。延长CRRT系统使用寿命的方法和程序可能会提高剂量输送。

相似文献

1
Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States.美国一家大型学术医疗中心的持续性肾脏替代治疗给药模式。
J Crit Care. 2002 Dec;17(4):246-50. doi: 10.1053/jcrc.2002.36757.
2
Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.重症监护病房中急性肾衰竭患者间歇性血液透析与连续性肾脏替代治疗的疗效观察分析
J Intensive Care Med. 2008 May-Jun;23(3):195-203. doi: 10.1177/0885066608315743.
3
A retrospective study of continuous renal replacement therapy versus intermittent hemodialysis in severe acute renal failure.一项关于连续性肾脏替代治疗与间歇性血液透析治疗重症急性肾衰竭的回顾性研究。
Chin Med J (Engl). 2001 Nov;114(11):1157-61.
4
Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.危重症外科患者的急性肾衰竭:尽管有新的肾脏替代治疗模式,但死亡率仍居高不下。
J Trauma. 2007 Nov;63(5):987-93. doi: 10.1097/TA.0b013e3181574930.
5
Renal replacement therapy for acute renal failure on the intensive care unit: coming of age?重症监护病房中急性肾衰竭的肾脏替代治疗:成熟了吗?
Neth J Med. 2003 Aug;61(8):239-48.
6
[Continuous renal replacement therapy for severe acute renal failure].[连续性肾脏替代疗法治疗重症急性肾衰竭]
Di Yi Jun Yi Da Xue Xue Bao. 2004 Dec;24(12):1388-90.
7
Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.在连续性肾脏替代治疗中,局部枸橼酸盐抗凝是否优于全身肝素抗凝?一项在成人区域重症监护系统中的前瞻性观察研究。
J Crit Care. 2005 Jun;20(2):155-61. doi: 10.1016/j.jcrc.2005.01.001.
8
Survival to discharge among patients treated with continuous renal replacement therapy.接受持续肾脏替代治疗的患者出院生存率。
Hemodial Int. 2006 Jan;10(1):82-7. doi: 10.1111/j.1542-4758.2006.01179.x.
9
Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.RIFLE分级对接受连续性肾脏替代治疗的急性肾损伤危重症患者预后的预测价值
Chin Med J (Engl). 2009 May 5;122(9):1020-5.
10
Long and short-term outcomes in patients requiring continuous renal replacement therapy post cardiopulmonary bypass.体外循环后需要持续肾脏替代治疗的患者的长期和短期预后。
Eur J Cardiothorac Surg. 2005 May;27(5):906-9. doi: 10.1016/j.ejcts.2005.01.057.

引用本文的文献

1
Continuous renal replacement therapy (CRRT) program initiation in PICU of a resource limited setting: a retrospective analysis of challenges and outcomes.资源有限环境下儿科重症监护病房连续肾脏替代治疗(CRRT)方案的启动:挑战与结果的回顾性分析
BMC Nephrol. 2025 Jul 14;26(1):386. doi: 10.1186/s12882-025-04255-4.
2
Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience.连续性肾脏替代治疗期间的标准化局部枸橼酸抗凝:单中心经验
Indian J Crit Care Med. 2024 Sep;28(9):859-865. doi: 10.5005/jp-journals-10071-24797. Epub 2024 Aug 31.
3
Programs and processes for advancing pediatric acute kidney support therapy in hospitalized and critically ill children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference.
住院及危重症儿童儿科急性肾支持治疗的推进方案与流程:第26届急性疾病质量改进倡议(ADQI)共识会议报告
Pediatr Nephrol. 2024 Mar;39(3):993-1004. doi: 10.1007/s00467-023-06186-4. Epub 2023 Nov 6.
4
The influence of continuous renal replacement therapy on 1,3-β-d-glucan levels in critically ill patients: a single-center retrospective propensity score study.连续性肾脏替代治疗对危重症患者 1,3-β-d-葡聚糖水平的影响:一项单中心回顾性倾向评分研究。
Ren Fail. 2023;45(2):2255680. doi: 10.1080/0886022X.2023.2255680. Epub 2023 Oct 2.
5
Anticoagulation in renal replacement therapies: Why heparin should be abandoned in critical ill patients?肾脏替代治疗中的抗凝:为何危重症患者应摒弃肝素?
Int Urol Nephrol. 2024 Apr;56(4):1383-1393. doi: 10.1007/s11255-023-03805-9. Epub 2023 Sep 27.
6
ISCCM Guidelines on Acute Kidney Injury and Renal Replacement Therapy.国际危重病医学会急性肾损伤及肾脏替代治疗指南
Indian J Crit Care Med. 2022 Oct;26(Suppl 2):S13-S42. doi: 10.5005/jp-journals-10071-24109.
7
How To Prescribe And Troubleshoot Continuous Renal Replacement Therapy: A Case-Based Review.如何开具和解决连续肾脏替代治疗处方:基于案例的复习。
Kidney360. 2020 Dec 14;2(2):371-384. doi: 10.34067/KID.0004912020. eCollection 2021 Feb 25.
8
Shionone Attenuates Sepsis-Induced Acute Kidney Injury by Regulating Macrophage Polarization the ECM1/STAT5 Pathway.紫穗槐二酮通过调节巨噬细胞极化的ECM1/STAT5途径减轻脓毒症诱导的急性肾损伤。
Front Med (Lausanne). 2022 Jan 24;8:796743. doi: 10.3389/fmed.2021.796743. eCollection 2021.
9
Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.非药物干预措施预防连续性肾脏替代治疗中体外循环凝血。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2.
10
Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.危重症患者连续性肾脏替代治疗剂量:一个名副其实的质量指标。
Nephron. 2021;145(2):91-98. doi: 10.1159/000512846. Epub 2021 Feb 4.